Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Aurora Cannabis Inc    ACB   CA05156X1087

AURORA CANNABIS INC (ACB)
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Canada's Aurora Cannabis boosts stake in Australia-based Cann Group

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/04/2017 | 05:19pm CET

(Reuters) - Canada's Aurora Cannabis Inc (>> Aurora Cannabis Inc) said on Monday it increased its stake in Australia-based Cann Group Ltd (>> Cann Group Ltd) to 22.9 percent from 19.9 percent, its latest move to expand in the cannabis industry.

(Reuters) - Canada's Aurora Cannabis Inc (>> Aurora Cannabis Inc) said on Monday it increased its stake in Australia-based Cann Group Ltd (>> Cann Group Ltd) to 22.9 percent from 19.9 percent, its latest move to expand in the cannabis industry.

Aurora, already Cann Group's largest shareholder, said it bought the shares at A$2.50 ($1.90) apiece.

Shares of Cann Group ended 4.7 percent higher at A$3.14 on the Australian Stock Exchange on Monday.

Cann Group was the first Australian company to receive a license to research and cultivate cannabis for medical purposes.

Aurora will also invest C$12 million ($9.4 million) in Canadian biotechnology company Radient Technologies Inc <RTI.V>. The investment will increase Aurora's stake in Radient to 19.18 percent from 8.8 percent.

The investments come as Aurora - one of Canada's biggest cannabis makers - looks to expand ahead of expectations that Canada will legalize the production, sale and consumption of recreational marijuana.

Aurora is also trying to buy medical marijuana company CanniMed Therapeutics Inc (>> CanniMed Therapeutics Inc), which last week adopted a "poison pill" plan to prevent a takeover.

Radient's stock rose nearly 10 percent on Monday on the TSX Venture Exchange.

(Reporting by Yashaswini Swamynathan and Taenaz Shakir in Bengaluru; editing by Sai Sachin Ravikumar)

Stocks mentioned in the article
ChangeLast1st jan.
CANN GROUP LTD 2.07% 2.96 End-of-day quote.5.84%
CANNIMED THERAPEUTICS INC 0.65% 35.67 End-of-day quote.55.42%
TORONTO-S&P/TSX COMP 0.84% 15638.5 End-of-day quote.-3.55%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AURORA CANNABIS INC
02/23AURORA CANNABIS : Appoints Andr Jrme SVP Business Integration
AQ
02/23Cannabis Leads Two Sectors on the TSXV 2018 Top 50
AQ
02/22AURORA CANNABIS : Appoints André Jérôme SVP Business Integration
AQ
02/20Cannabis Companies on Trajectory to Become Industry’s Top Investment Be..
AQ
02/16Pot Pharm - Booming Canada weed sector plots next-wave medicines
RE
02/16POT PHARM : Booming Canada weed sector plots next-wave medicines
RE
02/15Aurora Cannabis and Liquor Stores N.A. Complete Strategic Investment to Devel..
AQ
02/14LIQUOR STORES N A : Aurora Cannabis and Liquor Stores N.A. Complete Strategic In..
AQ
02/14AURORA CANNABIS : signs LOI with the Société des Alcools du Québec to Supply Can..
AQ
02/12AURORA CANNABIS : Grants Options
AQ
More news
News from SeekingAlpha
02/23CANOPY AND AURORA : Who Just Had The Better Quarter? 
02/21OrganiGram Is Undervalued 
02/21269 MARIJUANA STOCKS : Correction, Crash, Or Slow Descent? 
02/21Aurora Cannabis And The Dirty Little Secret Of The Pot Industry 
02/20Marijuana Stocks That Could Outpace The Market In 2018 
Financials ( CAD)
Sales 2018 70,6 M
EBIT 2018 -2,96 M
Net income 2018 19,9 M
Finance 2018 17,7 M
Yield 2018 -
P/E ratio 2018 268,00
P/E ratio 2019 59,56
EV / Sales 2018 71,0x
EV / Sales 2019 18,2x
Capitalization 5 032 M
Chart AURORA CANNABIS INC
Duration : Period :
Aurora Cannabis Inc Technical Analysis Chart | ACB | CA05156X1087 | 4-Traders
Technical analysis trends AURORA CANNABIS INC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 8,99  CAD
Spread / Average Target -16%
Managers
NameTitle
Terry Booth Chief Executive Officer & Non-Independent Director
Steve Dobler President & Director
Michael Singer Chairman
Allan Cleiren Chief Operating Officer
Glen W. Ibbott Chief Financial Officer
Sector and Competitors